Aditxt, Inc. cotiza a 0.00 USD y tiene una capitalización bursátil de $3M. En los últimos 12 meses ha facturado $14336 con un margen de flujo de caja libre del -804447.6%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Aditxt, Inc. focuses on discovery and development of biopharmaceutical products. The company develops AditxtScore and FlowSpot that enable individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic a…
| Periodo | 2023-11 | 2023-05 | 2023-04 | 2022-11 |
|---|---|---|---|---|
| Real | $-10534.33 | $-282.96 | $673.92 | $-1138.32 |
| Estimado | $-1723.68 | $-190.08 | $-319.68 | $-481.68 |
| Sorpresa | -511.2% | -48.9% | +310.8% | -136.3% |
| Métrica | ADTX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 8.4% | 57.0% | -48.6% |
| Operating Margin | -612542.2% | -38.6% | -612503.6% |
| Net Margin | -1349028.2% | -33.6% | -1348994.6% |
| FCF Margin | -804447.6% | -13.9% | -804433.8% |
| ROE | -768.3% | -40.4% | -727.9% |
| ROA | -261.0% | -32.0% | -228.9% |
| Current Ratio | 0.31 | 2.84 | -2.53 |
| Debt / Equity | — | 0.28 | — |